1-10 of 10
Maureen O’Brien
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Full CD34 Donor Chimerism Following CD34 Chimerism Directed Donor Lymphocyte Infusion Results in Reduced Relapse and Superior Overall Survival Compared with Mixed Chimerism Status in Allogeneic Haemopoietic Stem Cell Transplant Recipients

Joanne BL Tan, David J. Curtis, Jenny Muirhead, Michael Swain, Shaun Fleming, BIanca Cirone, Maureen O'Brien, Shu Min Wong, Shafqat Inam, Sushrut S. Patil, Andrew Spencer
Journal: Blood
Blood (2023) 142 (Supplement 1): 2239.
https://doi.org/10.1182/blood-2023-185307
Published: 2023
Journal Articles

High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial

Clinical Trials & Observations
Johann Hitzler, Todd Alonzo, Robert Gerbing, Amy Beckman, Betsy Hirsch, Susana Raimondi, Karen Chisholm, Shelton Viola, Lisa Brodersen, Michael Loken, Spencer Tong, Todd Druley, Maureen O’Brien, Nobuko Hijiya, Amy Heerema-McKenney, Yi-Chang Wang, Reuven Shore, Jeffrey Taub, Alan Gamis, E. Anders Kolb, Jason N. Berman
Journal: Blood
Blood (2021) 138 (23): 2337–2346.
https://doi.org/10.1182/blood.2021012206
Published: 2021
Includes: Supplemental data
Journal Articles

Peripheral Blood CD34 + Donor Chimerism Is Superior to CD3 + Donor Chimerism for Predicting Relapse Following Allogeneic Stem Cell Transplantation for Myeloid Malignancies

Tongted Das, PhD, Daniel North, Shaun Fleming, David Kliman, Andrew Spencer, Andrew H. Wei, Sushrut S. Patil, Jacueline Widjaja, Maureen O'Brien, David J. Curtis, MBBS,PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 47–48.
https://doi.org/10.1182/blood-2020-143465
Published: 2020
Journal Articles

Phase 1/2 Study in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Receiving Blinatumomab Treatment

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, Rupert Handgretinger, Tanya M. Trippett, Carmelo Rizzari, Christian M. Zwaan, Deepa Bhojwani, Steven G. Dubois, MD, Peter Bader, Arndt Borkhardt, Maureen O'Brien, Susan R. Rheingold, MD, Todd Michael Cooper, Kuolung Hu, Noemi Mergen, Anja Fischer, Min Zhu, Youssef Hijazi, James Whitlock, Lia Gore
Journal: Blood
Blood (2014) 124 (21): 2292.
https://doi.org/10.1182/blood.V124.21.2292.2292
Published: 2014
Journal Articles

Pediatric Experience with Low Dose Decitabine In Very High Risk Relapsed AML.

Christine L Phillips, MD, Stella M. Davies, MBBS, PhD, Richard McMasters, MD, Maureen O'Brien, MD, MS, Michael J. Absalon, MD, PhD, Jeffrey A. Moscow, MD, Teresa Smolarek, PhD, John P. Perentesis, MD
Journal: Blood
Blood (2010) 116 (21): 1070.
https://doi.org/10.1182/blood.V116.21.1070.1070
Published: 2010
Journal Articles

Myeloid Leukemia of Down Syndrome: The Results of An International Retrospective Study

Marjolein Blink, Marry M. Van den Heuvel-Eibrink, Válerie de Haas, MD, PhD, Henrik Hasle, MD, PhD, Maureen O'Brien, MD, MS, Batia Stark, Julie Tandonnet, MD, Andrea Pession, Katerina Tousovska, Daniel K.L. Cheuk, Kazuko Kudo, MD, Takashi Taga, MD, PhD, Jeffrey Rubnitz, MD, PhD, Irén Haltrich, Walentyna Balwierz, Bertil Johansson, MD, PhD, Martin Zimmermann, Dirk Reinhardt, MD, PhD, Rob Pieters, MD, PhD, Erik Forestier, Christian M. Zwaan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2718.
https://doi.org/10.1182/blood.V116.21.2718.2718
Published: 2010
Journal Articles

Acute Megakaryoblastic Leukemia (AMKL) in Children without Down Syndrome.

Maureen O'Brien, MD, Gary Dahl, MD, Stanley Pounds, Norman J. Lacayo, MD, Jeffrey Taub, MD, Myron Chang, Howard J. Weinstein, MD, Yaddanapudi Ravindranath, MBBS, Dario Campana, MD, PhD, Ching-Hon Pui, MD, Jeffrey Rubnitz, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 482.
https://doi.org/10.1182/blood.V114.22.482.482
Published: 2009
Journal Articles

Excessive Cardiotoxicity Despite Excellent Leukemia-Free Survival for Pediatric Patients with Down Syndrome (DS) and Acute Myeloid Leukemia (AML): Results from POG (Pediatric Oncology Group) Protocol 9421.

Maureen O’Brien, MD, Jeffrey Taub, MD, Kimo Stine, MD, Myron Chang, Yaddanapudi Ravindranath, MD, David Becton, MD, Gary Van Houten Dahl, MD
Journal: Blood
Blood (2006) 108 (11): 559.
https://doi.org/10.1182/blood.V108.11.559.559
Published: 2006
Journal Articles

Gene Expression Profiling Predicts Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Norman J. Lacayo, MD, Maureen O’Brien, MD, Shweta Jain, Soheil Meshinchi, MD, PhD, Ron Yu, PhD, Dejan Juric, MD, Myron N. Chang, PhD, Robert Tibshirani, PhD, Yaddanapudi Ravindranath, MD, Howard J. Weinstein, MD, Branimir I. Sikic, MD, Gary Van Houten Dahl, MD
Journal: Blood
Blood (2006) 108 (11): 1915.
https://doi.org/10.1182/blood.V108.11.1915.1915
Published: 2006
Journal Articles

Gene Expression Profiling and FLT3 Status Correlate with Outcome in De Novo Acute Myeloid Leukemia (AML) with Normal Karyotype: Results of Children’s Oncology Group (COG) Study POG #9421.

Norman Lacayo, MD, Soheil Meshinchi, MD, Susana Raimondi, PhD, Chitra Saraiya, MS, Maureen O’Brien, MD, Ronald Yu, PhD, Dejan Juric, MD, Myron Chang, PhD, Cheryl Willman, MD, Robert Tibshirani, PhD, Yaddanapudi Ravindranath, MD, Branimir Sikic, MD, Howard Weinstein, MD, Gary Van Houten Dahl, MD
Journal: Blood
Blood (2005) 106 (11): 2372.
https://doi.org/10.1182/blood.V106.11.2372.2372
Published: 2005